Natural and amyloid self-assembly of S100 proteins: Structural basis of functional diversity

FEBS Journal

Volumn 277, Issue 22, 2010, Pages 4578-4590

  Fritz, Günter ^a   Botelho, Hugo M ^b   Morozova Roche, Ludmilla A ^c   Gomes, Cláudio M ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloid; Fibril; Function; Metal ions; Misfolding; Oligomer; S100 proteins; Self assembly; Structure

Indexed keywords

AMYLOID; CALCIUM ION; COPPER ION; HOMODIMER; PROTEIN S 100; TOLL LIKE RECEPTOR 4; ZINC ION;

AUTOIMMUNE DISEASE; CANCER PATIENT; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HYPOTHESIS; IN VITRO STUDY; OLIGOMERIZATION; PLASTICITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN MOTIF; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; REVIEW;

AMYLOID; ANIMALS; CALCIUM; HUMANS; MALE; MODELS, MOLECULAR; PROSTATIC NEOPLASMS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; S100 PROTEINS; ZINC;

EID: 78049277867     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07887.x     Document Type: Review

References (87)

1. Moore BW (1965) A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19, 739-744.
2. Engelkamp D, Schäfer BW, Mattei MG, Erne P & Heizmann CW (1993) Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci USA 90, 6547-6551.
3. Schäfer BW, Wicki R, Engelkamp D, Mattei MG & Heizmann CW (1995) Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25, 638-643.
4. Salama I, Malone PS, Mihaimeed F & Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34, 357-364.
5. Boom A, Pochet R, Authelet M, Pradier L, Borghgraef P, Van Leuven F, Heizmann CW & Brion JP (2004) Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochim Biophys Acta 1742, 161-168.
6. Mrak RE & Griffinbc WS (2001) The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging 22, 915-922.
7. Botelho HM, Koch M, Fritz G & Gomes CM (2009) Metal ions modulate the folding and stability of the tumor suppressor protein S100A2. FEBS J 276, 1776-1786.
8. Heizmann CW & Cox JA (1998) New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals 11, 383-397.
9. Bjork P, Bjork A, Vogl T, Stenstrom M, Liberg D, Olsson A, Roth J, Ivars F & Leanderson T (2009) Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol 7, e97.
10. Leclerc E, Fritz G, Vetter SW & Heizmann CW (2009) Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793, 993-1007.
11. Ostendorp T, Leclerc E, Galichet A, Koch M, Demling N, Weigle B, Heizmann CW, Kroneck PM & Fritz G (2007) Structural and functional insights into RAGE activation by multimeric S100B. EMBO J 26, 3868-3878.
12. Donato R (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7, 711-724.
13. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, Van Zoelen MA, Nacken W, Foell D, Van Der Poll T, Sorg C et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13, 1042-1049.
14. Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, Brorsson AC, Tartaglia GG, Vogl T, Kayed R, Wingsle G et al. (2009) Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS ONE 4, e5562.
15. Koch M, Bhattacharya S, Kehl T, Gimona M, Vasak M, Chazin W, Heizmann CW, Kroneck PM & Fritz G (2007) Implications on zinc binding to S100A2. Biochim Biophys Acta 1773, 457-470.
16. Korndörfer IP, Brueckner F & Skerra A (2007) The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J Mol Biol 370, 887-898.
17. Moroz OV, Blagova EV, Wilkinson AJ, Wilson KS & Bronstein IB (2009) The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. J Mol Biol 391, 536-551.
18. Moroz OV, Antson AA, Dodson EJ, Burrell HJ, Grist SJ, Lloyd RM, Maitland NJ, Dodson GG, Wilson KS, Lukanidin E et al. (2002) The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr D Biol Crystallogr 58, 407-413.
19. Marlatt NM, Boys BL, Konermann L & Shaw GS (2009) Formation of monomeric S100B and S100A11 proteins at low ionic strength. Biochemistry 48, 1954-1963.
20. Santamaria-Kisiel L, Rintala-Dempsey AC & Shaw GS (2006) Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 396, 201-214.
21. Hunter MJ & Chazin WJ (1998) High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J Biol Chem 273, 12427-12435.
22. Nacken W & Kerkhoff C (2007) The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant. FEBS Lett 581, 5127-5130.
23. Vogl T, Leukert N, Barczyk K, Strupat K & Roth J (2006) Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim Biophys Acta 1763, 1298-1306.
24. Baudier J, Mandel P & Gerard D (1983) Bovine brain S100 proteins: separation and characterization of a new S100 protein species. J Neurochem 40, 145-152.
25. Yang Q, O'Hanlon D, Heizmann CW & Marks A (1999) Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma. Exp Cell Res 246, 501-509.
26. Deloulme JC, Assard N, Mbele GO, Mangin C, Kuwano R & Baudier J (2000) S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo. J Biol Chem 275, 35302-35310.
27. Wang G, Rudland PS, White MR & Barraclough R (2000) Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1. J Biol Chem 275, 11141-11146.
28. Wang G, Zhang S, Fernig DG, Spiller D, Martin-Fernandez M, Zhang H, Ding Y, Rao Z, Rudland PS & Barraclough R (2004) Heterodimeric interaction and interfaces of S100A1 and S100P. Biochem J 382, 375-383.
29. Lehmann R, Melle C, Escher N & Von Eggeling F (2005) Detection and identification of protein interactions of S100 proteins by ProteinChip technology. J Proteome Res 4, 1717-1721.
30. Vogl T, Roth J, Sorg C, Hillenkamp F & Strupat K (1999) Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 10, 1124-1130. doi: S1044-0305(99)00085-9 [pii].
31. Novitskaya V, Grigorian M, Kriajevska M, Tarabykina S, Bronstein I, Berezin V, Bock E & Lukanidin E (2000) Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem 275, 41278-41286. doi: [pii].
32. Rezvanpour A, Phillips JM & Shaw GS (2009) Design of high-affinity S100-target hybrid proteins. Protein Sci 18, 2528-2536.
33. 2+-free states. Biochemistry 38, 1695-1704.
34. Charpentier TH, Wilder PT, Liriano MA, Varney KM, Pozharski E, MacKerell AD Jr, Coop A, Toth EA & Weber DJ (2008) Divalent metal ion complexes of S100B in the absence and presence of pentamidine. J Mol Biol 382, 56-73. doi: S0022-2836(08)00763-8 [pii] 10.1016/j.jmb.2008.06.047.
35. 2+-free S100A2 at 1.6 A resolution. J Mol Biol 378, 933-942.
36. Glaser R, Harder J, Lange H, Bartels J, Christophers E & Schroder JM (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6, 57-64.
37. 2+ binding on S100b protein. J Biol Chem 261, 8192-8203.
38. Dell'Angelica EC, Schleicher CH & Santome JA (1994) Primary structure and binding properties of calgranulin C, a novel S100-like calcium-binding protein from pig granulocytes. J Biol Chem 269, 28929-28936.
39. Kerkhoff C, Vogl T, Nacken W, Sopalla C & Sorg C (1999) Zinc binding reverses the calcium-induced arachidonic acid-binding capacity of the S100A8/A9 protein complex. FEBS Lett 460, 134-138.
40. 2+ are essential for S100A12 protein oligomerization and function. BMC Biochem 10, 11.
41. Baudier J & Cole RD (1988) Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 263, 5876-5883.
42. Yu WH & Fraser PE (2001) S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. J Neurosci 21, 2240-2246.
43. Mbele GO, Deloulme JC, Gentil BJ, Delphin C, Ferro M, Garin J, Takahashi M & Baudier J (2002) The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes. J Biol Chem 277, 49998-50007.
44. Gentil BJ, Delphin C, Mbele GO, Deloulme JC, Ferro M, Garin J & Baudier J (2001) The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B. J Biol Chem 276, 23253-23261.
45. 2+ enhancement of the S100B binding epitope TRTK-12. J Biol Chem 274, 1502-1508.
46. Ionescu JG, Novotny J, Stejskal V, Latsch A, Blaurock-Busch E & Eisenmann-Klein M (2006) Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett 27(Suppl. 1), 36-39.
47. Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H, Wang X, Zhang S, Liuzzi JP, Chang SM, Cousins RJ et al. (2007) Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci USA 104, 18636-18641.
48. Nishikawa T, Lee IS, Shiraishi N, Ishikawa T, Ohta Y & Nishikimi M (1997) Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage. J Biol Chem 272, 23037-23041.
49. Schafer BW, Fritschy JM, Murmann P, Troxler H, Durussel I, Heizmann CW & Cox JA (2000) Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily. J Biol Chem 275, 30623-30630. doi: [pii].
50. Moroz OV, Antson AA, Grist SJ, Maitland NJ, Dodson GG, Wilson KS, Lukanidin E & Bronstein IB (2003) Structure of the human S100A12-copper complex: implications for host-parasite defence. Acta Crystallogr D Biol Crystallogr 59, 859-867.
51. Landriscina M, Bagala C, Mandinova A, Soldi R, Micucci I, Bellum S, Prudovsky I & Maciag T (2001) Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress. J Biol Chem 276, 25549-25557. doi: [pii].
52. Xie J, Burz DS, He W, Bronstein IB, Lednev I & Shekhtman A (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 282, 4218-4231.
53. Kiryushko D, Novitskaya V, Soroka V, Klingelhofer J, Lukanidin E, Berezin V & Bock E (2006) Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol Cell Biol 26, 3625-3638.
54. Mossberg A, Mok KH, Morozova-Roche LA & Svanborg C (2010) Structure and function of human α-lactalbumin made lethal to tumor cells (HAMLET)-type complexes. FEBS J 277, 4614-4625.
55. Zimmer DB & Van Eldik LJ (1986) Identification of a molecular target for the calcium-modulated protein S100. Fructose-1, 6-bisphosphate aldolase. J Biol Chem 261, 11424-11428.
56. Brozzi F, Arcuri C, Giambanco I & Donato R (2009) S100B protein regulates astrocyte shape and migration via interaction with Src kinase: implications for astrocyte development, activation, and tumor growth. J Biol Chem 284, 8797-8811.
57. Millward TA, Heizmann CW, Schafer BW & Hemmings BA (1998) Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J 17, 5913-5922.
58. Garbuglia M, Verzini M, Rustandi RR, Osterloh D, Weber DJ, Gerke V & Donato R (1999) Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization. Biochem Biophys Res Commun 254, 36-41.
59. Donato R (1987) Quantitative analysis of the interaction between S-100 proteins and brain tubulin. Cell Calcium 8, 283-297.
60. Kilby PM, Van Eldik LJ & Roberts GC (1997) Identification of the binding site on S100B protein for the actin capping protein CapZ. Protein Sci 6, 2494-2503.
61. Wright NT, Cannon BR, Wilder PT, Morgan MT, Varney KM, Zimmer DB & Weber DJ (2009) Solution structure of S100A1 bound to the CapZ peptide (TRTK12). J Mol Biol 386, 1265-1277.
62. Austermann J, Nazmi AR, Heil A, Fritz G, Kolinski M, Filipek S & Gerke V (2009) Generation and characterization of a novel, permanently active S100P mutant. Biochim Biophys Acta 1793, 1078-1085.
63. Koltzscher M, Neumann C, Konig S & Gerke V (2003) Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P. Mol Biol Cell 14, 2372-2384.
64. Baudier J, Delphin C, Grunwald D, Khochbin S & Lawrence JJ (1992) Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc Natl Acad Sci USA 89, 11627-11631.
65. Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M, Hochli M & Heizmann CW (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 280, 29186-29193.
66. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G et al. (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276, 22699-22708.
67. Ehrchen JM, Sunderkotter C, Foell D, Vogl T & Roth J (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86, 557-566. doi: jlb.1008647 [pii]
68. Foell D, Wittkowski H, Vogl T & Roth J (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81, 28-37. doi:
69. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, Nacken W, Klenner L, Kuhn A, Foell D, Sorokin L et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16, 713-717. doi:.
70. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H & Maru Y (2008) The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10, 1349-1355. doi:
71. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C & Giambanco I (2009) S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793, 1008-1022. doi: S0167-4889(08)00409-6 [pii] 10.1016/j.bbamcr.2008.11.009.
72. Businaro R, Leone S, Fabrizi C, Sorci G, Donato R, Lauro GM & Fumagalli L (2006) S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res 83, 897-906. doi:
73. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A et al. (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. carcinogenesis 29, 2035-2043. doi:
74. Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, Hashemi M, Eshraghi M, Schulze-Osthoff K, Klonisch T et al. (2008) S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta 1783, 297-311. doi:
75. Viemann D, Barczyk K, Vogl T, Fischer U, Sunderkotter C, Schulze-Osthoff K & Roth J (2007) MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program. Blood 109, 2453-2460. doi:
76. Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, McNeill KD, Hashemi M, Kerkhoff C & Los M (2010) S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 20, 314-331. doi:
77. Cross PA, Bartley CJ & McClure J (1992) Amyloid in prostatic corpora amylacea. J Clin Pathol 45, 894-897.
78. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB & Nelson WG (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7, 256-269.
79. McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS & Geczy CL (2005) S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280, 41521-41529.
80. Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2, 18.
81. Pedersen JS, Andersen CB & Otzen DE (2010) Amyloid structure - one but not the same: the many levels of fibrillar polymorphism. FEBS J 277, 4591-4601.
82. Otzen D & Nielsen PH (2008) We find them here, we find them there: functional bacterial amyloid. Cell Mol Life Sci 65, 910-927.
83. Tartaglia GG & Vendruscolo M (2008) The Zyggregator method for predicting protein aggregation propensities. Chem Soc Rev 37, 1395-1401.
84. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F & Vendruscolo M (2008) Prediction of aggregation-prone regions in structured proteins. J Mol Biol 380, 425-436.
85. Maurer-Stroh S, Debulpaep M, Kuemmerer N, De La Paz ML, Martins IC, Reumers J, Morris KL, Copland A, Serpell L, Serrano L et al. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods 7, 237-242.
86. Stefani M (2010) Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J 277, 4602-4613.
87. Heo C, Chang KA, Choi HS, Kim HS, Kim S, Liew H, Kim JA, Yu E, Ma J & Suh YH (2007) Effects of the monomeric, oligomeric, and fibrillar Abeta42 peptides on the proliferation and differentiation of adult neural stem cells from subventricular zone. J Neurochem 102, 493-500. doi: